The innovation of ARDEAPHARMA, a.s. (Q9941): Difference between revisions
Jump to navigation
Jump to search
(Created claim: summary (P836): ARDEAPHARMA, a.s. is a pharmaceutical company in the category of a small enterprise which is owned by Czech owners and is the only type of company operating on the Czech market alongside transnational pharmaceutical corporations. In almost 20 years, it shows positive farming and has not yet benefited from financial support from EU funds. The project focuses on product innovation and related innovation in the company’s production and control proc...) |
(Removed claims) |
||
| Property / instance of | |||
| Property / instance of: Kohesio project / rank | |||
| Property / financed by | |||
| Property / financed by: European Union / rank | |||
| Property / financed by | |||
| Property / financed by: Directorate-General for Regional and Urban Policy / rank | |||
Revision as of 16:21, 3 March 2020
Project in Czech Republic financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The innovation of ARDEAPHARMA, a.s. |
Project in Czech Republic financed by DG Regio |
Statements
6,300,000.0 Czech koruna
0 references
14,000,000.0 Czech koruna
0 references
45 percent
0 references
21 September 2015
0 references
19 September 2018
0 references
20 September 2018
0 references
ARDEAPHARMA, a.s.
0 references
49°5'42.72"N, 14°33'56.70"E
0 references
37363
0 references
ARDEAPHARMA, a.s. je farmaceutická společnost v kategorii malý podnik, která má české vlastníky a jako jediná svého druhu působí na českém trhu vedle nadnárodních farmaceutických korporací. V téměř 20-leté historii vykazuje kladné hospodaření a dosud nečerpala finanční podporu z fondů EU. Projekt je zaměřen na inovaci výrobků a související inovaci výrobního a kontrolního procesu společnosti, s cílem posílit konkurenceschopnost jak na domácím trhu, tak i směrem k zahraničí. a. (Czech)
0 references
ARDEAPHARMA, a.s. is a pharmaceutical company in the category of a small enterprise which is owned by Czech owners and is the only type of company operating on the Czech market alongside transnational pharmaceutical corporations. In almost 20 years, it shows positive farming and has not yet benefited from financial support from EU funds. The project focuses on product innovation and related innovation in the company’s production and control process, with a view to enhancing competitiveness both on the domestic market and towards the rest of the world. (English)
0 references
Identifiers
CZ.01.1.02/0.0/0.0/15_014/0004450
0 references